Estimation of the Serum Level of Poly Adenosine Diphosphate Ribose Polymerase-1 in Psoriasis and its Correlation with Disease Severity

Kamel, Hanan Abd El-Razik; Othman, Alaa Rajab; El-Rifaie, Abd El-Aziz Abd El-Salam; Ryad, Hoda Ramadan

doi:10.21608/ejmr.2024.277295.1589

Estimation of the Serum Level of Poly Adenosine Diphosphate Ribose Polymerase-1 in Psoriasis and its Correlation with Disease Severity

Document Type : Original Article

Authors

¹ Department of dermatology, Faculty of Medicine, Beni-Suef University.

² Department of Biochemistry, Faculty of Medicine, Beni-Suef University.

10.21608/ejmr.2024.277295.1589

Abstract

Background: Psoriasis is a complicated inflammatory condition of chronic nature with several etiologies. In addition to an increase in the turnover rate of epidermal cells, psoriasis is characterized by hyperproliferation of keratinocytes in the epidermis. Objective: The objective of the current study was to determine the level of PARP-1 in psoriasis patients compared to healthy controls and its relationship to the severity of the disease. Blood samples from 40 patients with fully developed psoriasis were collected, and each patient's PASI (Psoriasis Areas and Severity Index) score was determined. Patients and methods: Blood samples from 40 healthy volunteers who had no history of psoriasis were also collected, and those blood samples were analyzed using ELISA (enzyme-linked immunosorbent assay). Results: This study provides that the serum level of poly ADP ribose polymerase-1 was significantly higher in patients compared with the controls with no correlation to age, sex or family history (P-value = 0.020). Additionally, the research found no association between the PASI score and the blood level of PARP-1 in psoriatic individuals (r = 0.156, p-value = 0.337). Conclusion: We came to the conclusion that PARP-1 could be involved in the pathogenesis of psoriasis and PARP inhibitors might be an effective adjunct to current anti-psoriatic therapies.

Keywords

Main Subjects

Internal medicine ·

References

Parisi R., Iskandar I.Y.K., Kontopantelis E., Augustin M., Griffiths C.E.M., Ashcroft D.M. (2020): National, Regional, and Worldwide Epidemiology of Psoriasis: Systematic Analysis and Modelling Study. BMJ. 369:m1590.
Ogawa E., Okuyama R., Seki T., Kobayashi A., Oiso N., Muto M., Nakagawa H., Kawada A. (2018): Epidemiological Survey of Patients with Psoriasis in Matsumoto City, Nagano Prefecture, Japan. J. Dermatol. 45:314–317.
Jindal S., Awasthia R., Singharec D., Kulkarni G.T. (2020): Topical delivery of Tacrolimus using liposome containing gel: An emerging and synergistic approach in management of psoriasis. Medical hypotheses journal.
Chen H, Liu H, Lu C, Wang M, Li X, Zhao H, Yan Y, Yu W, Han L, Dai Z. (2018): PSORI-CM02 Formula increases CD4+ Foxp3+ regulatory T cell frequency and ameliorates imiquimod-induced psoriasis in mice. Front Immunol. 8:1767.
Tiwari, P., Khan, H., Singh, T. G., & Grewal, A. K. (2022). Poly (ADP-ribose) polymerase: an overview of mechanistic approaches and therapeutic opportunities in the management of stroke. Neurochemical Research, 47(7), 1830-1852.
Martinez-Morcillo, F. J., Canton-Sandoval, J., Martínez-Menchón, T., Corbalán-Vélez, R., Mesa-del-Castillo, P., Perez-Oliva, A. B., ... & Mulero, V. (2021). Non-canonical roles of NAMPT and PARP in inflammation. Developmental & Comparative Immunology, 115, 103881.
El Latif, A. A., Zahra, A. E. A., Badr, A., Elbialy, Z. I., Alghamdi, A. A., Althobaiti, N. A., ... & Abouzed, T. K. (2023). The potential role of upregulated PARP-1/RIPK1 expressions in amikacin-induced oxidative damage and nephrotoxicity in Wistar rats. Toxicology Research, 12(5), 979-989
Das, S., Chen, Y., Yan, J., Christensen, G., Belhadj, S., Tolone, A., & Paquet-Durand, F. (2021). The role of cGMP-signalling and calcium-signalling in photoreceptor cell death: Perspectives for therapy development. Pflügers Archiv-European Journal of Physiology, 473, 1411-1421.
Dhahri, H., & Fondufe‐Mittendorf, Y. N. (2023). Exploring the interplay between PARP1 and circRNA biogenesis and function. Wiley Interdisciplinary Reviews: RNA, e1823.
Ray Chaudhuri, A., & Nussenzweig, A. (2017). The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nature reviews Molecular cell biology, 18(10), 610-621.
Huang, P., Chen, G., Jin, W., Mao, K., Wan, H., & He, Y. (2022). Molecular mechanisms of parthanatos and its role in diverse diseases. International Journal of Molecular Sciences, 23(13), 7292.
Martínez-Morcillo FJ, Cantón-Sandoval J, Martínez-Navarro FJ, Cabas I, Martínez-Vicente I, Armistead J, et al. (2021): NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death. PLoS Biol. 8;19(11):e3001455.
Martínez-Morcillo FJ. (2019): Elucidating the role of Nampt and PARP-1 in chronic inflammatory skin diseases. Department of Cellular Biology and Histology, Faculty of Biology, University of Murcia.
Ghonim MA, Abouzeid MA, Pyakurel K, Wang J, Tarhuni A, Boulares H. (2018): Poly ADP-Ribose Polymerase (PARP)-1 Is A critical Determinant of Atopic Dermatitis through Control of Allergen-Induced Th2 And T-regulatory Responses And Expression of The Matricellular Protein Periostin. The FASEB Journal Volume 31, Issue S1 p. 995.13-995.13.
Brunyánszki A, Hegedus C, Szántó M, Erdélyi K, Kovács K, Schreiber V, et al. (2010): Genetic ablation of PARP-1 protects against oxazolone-induced contact hypersensitivity by modulating oxidative stress. J Invest Dermatol .130(11):2629-37.
Namazi MR. (2003): Nicotinamide: a potential addition to the anti-psoriatic weapon. FASEB J. 17(11):1377-9.
Kiss B, Szántó M, Hegedűs C, Antal D, Szödényi A, Márton J, et al. (2020): Poly(ADP-ribose) polymerase-1 depletion enhances the severity of inflammation in an imiquimod-induced model of psoriasis. Exp Dermatol. 29(1):79–85.
Kunze FA, Hottiger MO. (2019): Regulating Immunity via ADP-Ribosylation: Therapeutic Implications and Beyond. Trends in Immunology, Vol. 40, pp. 159–173.